Keywords: medimmune, reaches, quarter-year, eps, drugmaker, posted, net
MedImmune reaches $0.45 quarter-year EPS
Article | 22 April 2005
US drugmaker MedImmune has posted net earnings for the 2005 first quarter of $114.0 million, or $0.45 diluted earnings per share, from $111.0 million ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
